Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR headsets tested to ease End-of-Life distress

NCT ID NCT07109050

Symptom relief Sponsor: University of Lincoln Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study tests whether using a virtual reality headset can help people receiving palliative care achieve personal goals, such as relaxation or bucket-list experiences. Up to 12 patients and their companions will try up to 3 VR sessions. Researchers will track mood, anxiety, and goal progress to see if VR is effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality headset
What this could lead to
If it works, this could show that VR is a useful tool for improving wellbeing and achieving personal goals in palliative care.
What could go wrong
This is a very small study (12 people) with no control group, so results may not apply widely. It only measures short-term effects, and VR may not help everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

8 people

The number who actually took part.

Started

Aug 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: Participants recieving palliative care must be: * Aged 18 or over (no upper age limit due to the service being lifelong). * Patients deemed to be palliative, receiving specialist care at the designated hospice as either an inpatient or outpatient. * Willing and able to engage in VR interventions as determined by the patients' usual care team. * Able to consent to the research, as assessed by the clinical psychologist supporting recruitment and the primary researcher delivering the VR intervention. Participant companions (carers, relatives) must be: * Aged 18 or over (no upper age limit). * Willing and able to engage in VR interventions and travel to the designated hospice site. * Able to consent to the research, as assessed by the clinical psychologist supporting recruitment and the primary researcher delivering the VR intervention. Exclusion criteria: * Lacking capacity to consent to take part in research as assessed by both the clinical psychologist supporting recruitment and the primary researcher delivering VR. * Exhibiting contraindications as set out by care team including eyesight impairments or neurological conditions such as epilepsy or dementia.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Palliative care are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Palliative care Virtual reality Wellbeing

Contacts and locations

Locations

  • University of Lincoln

    Lincoln, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.